CARMEL, Ind., July 16, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it is giving away its AI developed by the Company for redacting personally identifiable information in line with HIPAA regulations. Syra Health is giving the configurable solution to the healthcare and technology community for its use in redacting personally identifiable information or for expanding on its use in new ways.

"At Syra Health we understand just how complex HIPAA plus AI can be," said Travis Somerville, AI Leader for Syra Health. "That's why we are sharing a piece of our artificial intelligence. AI is constantly getting smarter, so the algorithm we are providing includes our knowledge, runs privately offline, and can be enhanced through others' additional use and expansion as they see fit." 

"Our AI Governance is committed to the ethical, responsible, and open-source use of AI," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "By utilizing our AI, we safeguard personally identifiable information while promoting widespread compliance with HIPAA."

Those interested in obtaining the personally identifiable information redaction code should complete this form. Syra Health plans to host a series of webinars explaining how to utilize and collaborate with the AI code. The Company will also share best cyber security practices for protecting an organization's personally identifiable information data.

Syra Health announced its AI Giveaway in the spirit of open-source collaboration and as part of Artificial Intelligence Appreciation Day, a day to recognize the benefits of AI.

ABOUT SYRA HEALTH

Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit www.syrahealth.com.

FORWARD-LOOKING STATEMENTS

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts

For Media Inquiries:

Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it.